Prytime Medical is an innovative medical device company that designs, develops and commercializes minimally invasive solutions for vascular trauma.
The company’s flagship product is the ER-REBOA™ Catheter, a 7 Fr compatible balloon catheter designed specifically for rapid, temporary occlusion of large vessels in the emergency and critical care environment during REBOA (Resuscitative Endovascular Occlusion of the Aorta) procedure.
The underlying intellectual property for the ER-REBOA™ Catheter was conceived by experienced military vascular and trauma surgeons, COL. Todd Rasmussen and Dr. Jonathan Eliason based on lessons learned in war in 2010.
The first guidewire free prototype was developed and tested on animals in 2011 and shortly after, the company was founded.
The ER-REBOA™ Catheter received 510(K) on October 23, 2015 and started commercializing in 2016.
In November 2016 Prytime Medical was approved to commercialize ER-REBOA™ Catheter in Europe. Prytime Medical plans a targeted roll out of the ER-REBOA™ Catheter to key physicians in the near future.